Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well done for putting this out there. i'm one of the three hundred sat awaiting the updates and the cash, the one that literally got away into the far distance and beyond.
It is 10 years since CIC was delisted on the 2nd May 2104.
Valuation at that time was £11m with 300 investers,
CONGRATULATIONS ARE DUE TO MR STUART BROMLEY.
Its time to congratulate Mr Stuart Bromley as it is his "10 YEAR" anniversary TODAY, the 2nd May 2024.
It is now 10 long painfull years since Mr Stuart Bromley pulled off one of the biggest illusions (smoke and mirrors) on the Aim market by delisting CIC company valued at £11,000,000 on the 2nd May 2014.
The 300 shareholders have not seen a penny of this money despite numerous promises of re-listing in five countries.
How I wish I had NEVER met STUART BROMLEY. !!!!!!!!!!!!!
Ps, Just as a matter of interest Stuart, how are:-
CIC Gold Ltd
CIC Coal Brancepeth
CIC Fuels
CIC Sino Reservers
CIC Fund
CIC Capital
CIC Seychelles
Plus the other 27 IPO’s in the pipe line.!!!
Getting along,
Think the only one that is doing very well is CIC Bromley.
Mmmm shame, if ever a time to own gold! not surprised
Just had a message from my broker cicc gold shares have been liquidated.
Hopefully, they can get a market listing in 2024 but it will be a long road till they can get FDA approval.
Here is a link to the FDA site if you want to look and are still in this world and need to look.
https://www.fda.gov/medical-devices/device-approvals-denials-and-clearances/recently-approved-devices
What of all these other companies Stuart is involved with and will there be any reward for long-suffering CIC shareholders?
A similar theme that Stuart has been weaving for years.
Live Long and Prosper....
Https://www.securitisation.com/copy-of-securitisation-platform
Just seen Stuart’s LinkedIn post worth reading albeit quite difficult to fully comprehend!
Just go on linkedin and look up stuart bromley
I can not see reference to new prospectus on website unless I am missing something ?
Cheers mac.
Can you post a link to CIC Group on Linkedin?
On linkedin
CIC Group is pleased to progressed 4 significant regulated IPOs as principal Transaction Advisor and prospectus promoter.
Fist half 2024 see continued progress in our investments.
CIC DeFi is also reaping the benifit's from is own Blockchain and AI platforms with significant large corporation sign on clients.
Can you post a website link macca? I can't find it.
If this link does not work the PDF should be showing on the Innomed website soon.
https://apis.mail.yahoo.com/ws/v3/mailboxes/@.id==VjN-2mFi47XWPM-qZeZS37jaXC3ieV8zMVgmCzZjwMIxVJiwsJ_-O8z7iO6TRKkPJvRXGl2LEeEb8L4Fd0GBJs5fOA/messages/@.id==AMzh_rEhz6vDZUmWBQEhENTq8Fs/content/parts/@.id==2.2/refresh?appid=YMailNorrinLaunch&ymreqid=edf9adfa-3430-0c4e-1cb9-e40000013f00
Thank you for the update , still more patience required then.
Ask Stuart......He should know if it is still possible.
I have some electronic certificates that I can print but the shares still show in my Barclays account.
Three years to wait for CIC Gold? More like thirty years at this rate. Not in my lifetime.
Thanks for the new info.
Macnai
I believe you went digital with your shares.
What did you have to do??
Spoke to Stuart last week
Expects listing of innomed by year end
Has 17 companies wanting to list but as you can see how difficult it is to float a company on the stock market.
Says he has
Some kind of banking license which is worth around £300 million has Jp Morgan and another who have joined in partnership to utilise this.
I believe this license was for the main Chinese Cicc and was hood winked in giving it to the wrong company .
Well done Stuart let’s see the benefits soon from it .
Said he is to busy to do anything with Cicc gold for the next three years .
Expect a dividend??? Believe it when I see it.
Said it would be easier if our shares were not log with the likes of Barclays.
I assume this is
To issue divs
Still confused to wether to write off
Both investments with the tax office as I didn’t get a straight answer .
If I get $6 for my complete holding, I’ll be shocked.
These shares are easily going to make me a millionaire one day. if we get $6 a share i’ll bag a few million which will be fine
Iii) the claw back of 6.5 million common shares awarded to insiders incorrectly awarded before April 15, 2021,
I hope that's not us!
The United States of America and European patent applications having made significant progress to date.
PureFlowCath Medical Device Update
The Company completed Phase One (and extension), Proof of Concept, work with Paragon Medical in May 2023.
Phase Two will be a significant investment to produce a working prototype suitable for the commencement of testing. The Company is currently scoping the detailed work to be conducted to effectively engage with potential developers ensuring stewardship of the Company funds. The Company’s aim is to progress as quickly as practical but due to the novelty of our product the process of specification, tendering and negotiation will take a few months. Management is aiming to have the contract in place in Q4 2023 but given the complexity it is expected that the contract to develop the Prototype will likely be let early in 2024.
Capital Resources to Fund Working Capital
The Company has agreed terms with CIC Fund Securitisation S.A. to provide debt finance of up to Euro €5,000,000 (the “Facility”) thereby securing working capital funding. The Company has drawn down Euro €1,600,000 to date, fully funding its working capital requirements for 2023 with a cash contingency reserve.
The Company has preserved working capital funds by agreement with CIC Capital Ltd. to convert nine months Transaction Advisor fees to debt notes thereby preserving the outflow of working capital funds. This was an independently approved related party transaction.
We are pleased to advise that existing shareholders have provided additional equity investment during 2023 at the same price per share of 29 cents with a warrant.
Invested Value Risk Minimisation
The Company has provided a risk minimisation mechanism for equity subscribers through a “Top-Up” provision should the listed share price be lower than 29 US cents per share. The Top-Up option will fall away after 30-days post trading.
The Top-Up provision allows for additional shares (rounded up), with warrants, to be issued at a discount of 20% to the current trading price if trading price in less that 29 US cents per share to compensate for the notional reduction of investment.
Value Accretion
Innomed Tech is advancing quickly, progressing on product and corporate fronts, focused on delivering useful medical products and thereby increased shareholder value. Peer analysis shows that on completion of the prototype to medical product, FDA approvals and further patent award will deliver on the potential for significant value accretion.
Peer analysis with medical device companies with approved medical device and all FDA approvals is between US$4 to $16 per share. Please note this is a forward-looking statement and shareholders should not rely on such statements.
www.InnomedTec.com
Billy Williams Disclosure Officer/Director +1 251 786 4695 BWilliams@InnomedTec.com